Bimonthly, Established in 1959
Open access journal


Sildenafil Drug Interactions & Contra-indications — 2025 Safety Checklist

Sildenafil: Quick Interaction Grid (2025)
Category Examples Action
Absolute CI Nitrates, Riociguat Contra-indicated
Strong CYP3A4 inhib. Ritonavir, Ketoconazole Start 25 mg; max 25/48 h
α-Blockers Tamsulosin, Doxazosin Separate ≥ 4 h
Inducers Rifampin, Bosentan Consider 150–200 mg
Additive BP Drop Amlodipine, Alcohol ↑ Monitor BP

Absolute Contra-indications

  • Nitrates (e.g., nitroglycerin, isosorbide): Severe hypotension risk. Never combine.
  • Riociguat: Soluble guanylate cyclase stimulator. Profound BP drop./li>
  • Recent MI or stroke (<6 months): Cardiac instability. Avoid use. [PubMed]
  • Severe hypotension (<90/50 mmHg): Baseline low BP. Contra-indicated.
  • Known hypersensitivity: Allergy to sildenafil or excipients.

Major Caution & Dose-Adjust – CYP3A4 Inhibitors

  • Ritonavir, indinavir: Potent CYP3A4 inhibitors. Max 25 mg/48h. [PubMed]
  • Ketoconazole, itraconazole: Strong inhibitors. Start low, titrate carefully.
  • Erythromycin, clarithromycin: Moderate inhibitors. Monitor for side effects.
  • Grapefruit juice: May increase sildenafil levels. Limit intake.
  • Saquinavir, atazanavir: HIV protease inhibitors. Use lowest dose possible.

Additive Hypotension – α-blockers, Alcohol, Antihypertensives

  • α-Blockers (tamsulosin, doxazosin): Separate doses by ≥4 hours to reduce syncope risk.
  • Alcohol (excess): Increases vasodilation, may cause dizziness/fainting.
  • Amlodipine, other CCBs: Additive BP lowering. Monitor closely.
  • ACE inhibitors, ARBs: Cumulative hypotensive effect possible.
  • Diuretics: May potentiate BP drop, especially in elderly.

Special Populations

  • Severe renal impairment (CrCl <30 ml/min): Start at 25 mg; titrate with caution.
  • Severe hepatic impairment: Use lowest dose; monitor for adverse effects.
  • Retinitis pigmentosa: Rare hereditary eye disease; avoid use (risk of vision loss).
  • Age >65 years: Increased sensitivity; consider lower starting dose.
  • Bleeding disorders: Use with caution; theoretical risk of epistaxis/bleeding.